Bruton tyrosine kinase
| GO Term | Evidence Code | PMID |
|---|---|---|
| neutrophil homeostasis |
|
|
| positive regulation of type III hypersensitivity |
|
|
| positive regulation of type I hypersensitivity |
|
|
| negative regulation of cytokine production |
|
|
| adaptive immune response |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| protein kinase activity |
|
|
| protein tyrosine kinase activity |
|
|
| protein tyrosine kinase activity |
|
|
| protein tyrosine kinase activity |
|
|
| protein tyrosine kinase activity |
|
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0050746 | mantle cell lymphoma | |
| DOID:0060875 | isolated growth hormone deficiency type III | |
| DOID:14179 | X-linked agammaglobulinemia | |
| DOID:2583 | agammaglobulinemia | |
| DOID:3234 | central nervous system lymphoma | |
| DOID:707 | B-cell lymphoma | |
| DOID:8584 | Burkitt lymphoma |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026